S. Pearce-kelling
发表
W. Hauswirth,
T. Aleman,
A. Cideciyan,
2005,
Molecular therapy : the journal of the American Society of Gene Therapy.
Weng Tao,
Rong Wen,
G. Acland,
2002,
Investigative ophthalmology & visual science.
Jean Bennett,
Artur V. Cideciyan,
Samuel G. Jacobson,
2001,
Nature Genetics.
Alexander Sumaroka,
T. Aleman,
A. Cideciyan,
2005,
Proceedings of the National Academy of Sciences of the United States of America.
A. J. Roman,
W. Hauswirth,
T. Aleman,
2006,
Human gene therapy.
D. M. Tait,
T. Aleman,
S. Jacobson,
2022
.
K. Ray,
G. Acland,
G. Aguirre,
1998,
Molecular vision.
K. Ray,
G. Acland,
G. Aguirre,
1997,
Experimental eye research.
E. Ostrander,
H. Parker,
Q. M. Khan,
2020,
PLoS genetics.
T. Aleman,
A. Cideciyan,
S. Jacobson,
2002,
Proceedings of the National Academy of Sciences of the United States of America.
T. Aleman,
S. Jacobson,
G. Acland,
2001,
Molecular vision.
Genomic deletion of CNGB3 is identical by descent in multiple canine breeds and causes achromatopsia
G. Acland,
H. Huson,
A. Komáromy,
2013,
BMC Genetics.
G. Aguirre,
T. Leeb,
V. Jagannathan,
2020,
Scientific Reports.
A. J. Roman,
W. Hauswirth,
T. Aleman,
2006,
Molecular therapy : the journal of the American Society of Gene Therapy.
A. Boyko,
C. Bustamante,
J. Mezey,
2010,
Molecular vision.
G. Acland,
G. Aguirre,
W. Beltran,
2009,
Investigative ophthalmology & visual science.
Canine RD3 mutation establishes rod-cone dysplasia type 2 (rcd2) as ortholog of human and murine rd3
G. Acland,
G. Aguirre,
A. Swaroop,
2009,
Mammalian Genome.
G. Acland,
G. Aguirre,
W. Beltran,
2008
.
G. Acland,
G. Aguirre,
A. Philp,
2006,
Genomics.
G. Acland,
G. Aguirre,
K. Palczewski,
2004,
Journal of Biological Chemistry.